← Eichor
Condition: Alcohol Related Liver Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alcohol Related Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT04088370Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Phase 3 · 1 location(s) · University Hospital, Lille · NCT06956482Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NA · 1 location(s) · Henry Ford Health System · NCT06269510CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Identification of Hepatic Fibrosis Using 4D-MRI
NA · 2 location(s) · University Hospital, Basel, Switzerland · NCT05385237Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · 84 location(s) · Bausch Health Americas, Inc. · NCT07428538Intra-Hepatic Microbiota in Alcoholic Hepatitis
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06307964Comparison of ALD, NASH, and Healthy Control Patients
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT03224949Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and T
NA · 1 location(s) · Stephanie Gräger · NCT06814990Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
Phase 1/Phase 2 · 1 location(s) · Prasun Kumar Jalal · NCT05006430Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NA · 3 location(s) · University of Wisconsin, Madison · NCT06305624Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
NA · 1 location(s) · Johns Hopkins University · NCT03845205Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
NA · 1 location(s) · The Cleveland Clinic · NCT04858412A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease
NA · 1 location(s) · The University of Hong Kong · NCT07450144Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191Optimized Remission in Alcohol-related Liver Cirrhosis
NA · 1 location(s) · Copenhagen University Hospital, Hvidovre · NCT06866496A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Y
Phase 2 · 131 location(s) · GlaxoSmithKline · NCT06613698Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Phase N/A · 1 location(s) · HepQuant, LLC · NCT07060547Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic He
NA · 1 location(s) · Bioaraba Health Research Institute · NCT05294744Tirzepatide in MetALD
Phase 2 · 1 location(s) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT07046819LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069The Liver Care Trial
NA · 2 location(s) · Zealand University Hospital · NCT05855031French National MICMAF Cohort
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05895890SAMe Trial for Patients With Alcoholic Cirrhosis
Phase 2 · 2 location(s) · Indiana University · NCT04250259Recompensation in Alcohol Related Hepatitis
NA · 1 location(s) · Nina Kimer · NCT06740318Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients W
Phase N/A · 9 location(s) · University Hospital, Lille · NCT04106518
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.